摘要
蛇是迷人的生物,在古代人类居住在地球之前,已经是这个星球的居民。毒蛇一直是恐惧的数字,并在全世界造成显着的死亡。毒液构成了具有各种异构体的蛋白质和肽的家族,使其成为不同分子的混合物。这些生物分子是造成受害者基本生理系统紊乱的原因,导致发病,如果不治疗,可导致死亡。研究人员通过技术进步将这些危及生命的毒素转化为拯救生命的治疗药物。由于卡托普利的发展,第一种衍生自黄芪的缓激肽增效肽的药物,对某些类型的癌症具有强力活性的解毒素,蛇毒组分对于新药的铅化合物的发展具有很大的潜力。蛇毒新药从凝血病和止血到抗癌药物的不断发展。在这次审查中,我们专注于临床使用或发展阶段的不同蛇毒蛋白
关键词: 蛇毒素,治疗剂,毒液诊断工具,抗凝剂,药物发现和开发,肽药物,制药工业,纤维蛋白密封剂,奥米科技。
Current Medicinal Chemistry
Title:Snake Venom: From Deadly Toxins to Life-saving Therapeutics
Volume: 24 Issue: 17
关键词: 蛇毒素,治疗剂,毒液诊断工具,抗凝剂,药物发现和开发,肽药物,制药工业,纤维蛋白密封剂,奥米科技。
摘要: Snakes are fascinating creatures and have been residents of this planet well before ancient humans dwelled the earth. Venomous snakes have been a figure of fear, and cause notable mortality throughout the world. The venom constitutes families of proteins and peptides with various isoforms that make it a cocktail of diverse molecules. These biomolecules are responsible for the disturbance in fundamental physiological systems of the envenomed victim, leading to morbidity which can lead to death if left untreated. Researchers have turned these life-threatening toxins into life-saving therapeutics via technological advancements. Since the development of captopril, the first drug that was derived from bradykininpotentiating peptide of Bothrops jararaca, to the disintegrins that have potent activity against certain types of cancers, snake venom components have shown great potential for the development of lead compounds for new drugs. There is a continuous development of new drugs from snake venom for coagulopathy and hemostasis to anti-cancer agents. In this review, we have focused on different snake venom proteins / peptides derived drugs that are in clinical use or in developmental stages till to date. Also, some commonly used snake venom derived diagnostic tools along with the recent updates in this exciting field are discussed.
Export Options
About this article
Cite this article as:
Snake Venom: From Deadly Toxins to Life-saving Therapeutics, Current Medicinal Chemistry 2017; 24 (17) . https://dx.doi.org/10.2174/0929867324666170605091546
DOI https://dx.doi.org/10.2174/0929867324666170605091546 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Patents on Emerging Therapeutics for the Treatment of Glaucoma, Age Related Macular Degeneration and Uveitis
Recent Patents on Biomedical Engineering (Discontinued) Subject Index To Volume 4
Current Vascular Pharmacology In vitro and in silico Evaluation of Non-Quaternary Reactivators of AChE as Antidotes of Organophosphorus Poisoning - a New Hope or a Blind Alley?
Medicinal Chemistry Cyclic Nucleotides Signaling and Phosphodiesterase Inhibition: Defying Alzheimer’s Disease
Current Drug Targets Atrial Tachycardias Occurring Late After Open Heart Surgery
Current Cardiology Reviews Fluoroquinolones, the Cornerstone of Treatment of Drug-Resistant Tuberculosis: A Pharmacokinetic and Pharmacodynamic Approach
Current Pharmaceutical Design A<sub>3</sub> Adenosine Receptor: A Plausible Therapeutic Target for Cardio-Protection in Diabetes
Recent Patents on Cardiovascular Drug Discovery Terminalia arjuna in Cardiovascular Diseases: Making the Transition from Traditional to Modern Medicine in India
Current Pharmaceutical Biotechnology The Development of Topically Acting Carbonic Anhydrase Inhibitors as Antiglaucoma Agents
Current Topics in Medicinal Chemistry Amniotic Fluid Embolism: What Level of Scientific Evidence can be Drawn? A Systematic Review
Current Pharmaceutical Biotechnology Transcranial Doppler Ultrasonography: Current Status
Current Medical Imaging A Systematic Review on Levosimendan in Paediatric Patients
Current Vascular Pharmacology Schiff Bases of Istain: Potential Anti-Leishmanial Agents
Letters in Drug Design & Discovery Potential Biomarkers for Depression Associated with Coronary Artery Disease: A Critical Review
Current Molecular Medicine Erectile Dysfunction as a Cardiovascular Risk Factor: Time to Step Up?
Current Vascular Pharmacology C5a, a Therapeutic Target in Sepsis
Recent Patents on Anti-Infective Drug Discovery Localisation of Endothelin-1 and its Receptors in Vascular Tissue as Seen at the Electron Microscopic Level
Current Vascular Pharmacology Role of CGRP-Receptor Component Protein (RCP) in CLR/RAMP Function
Current Protein & Peptide Science Advanced Drug Delivery of N-Acetylcarnosine (N-Acetyl-beta-alanyl-Lhistidine), Carcinine (Beta-alanylhistamine) and L-carnosine (Beta-alanyl- L-histidine) in Targeting Peptide Compounds as Pharmacological Chaperones for Use in Tissue Engineering, Human Disease Management and Therapy: From in vitro to the Clinic
Recent Patents on Drug Delivery & Formulation Atypical Antipsychotics: Pharmacokinetics, Therapeutic Drug Monitoring and Pharmacological Interactions
Current Medicinal Chemistry